Skip to main content
The Sport, Exercise, Nutrition and Public Health Research Group (SENPHRG) that brings together a diverse array of researchers from across the Faculty of Science, Engineering and Computing.
Our research aims to investigate the impact of sport, nutrition and exercise on health, well being, disease and human performance as well as the influence of human behaviour and public health initiatives on long term health through inter-disciplinary research.
Our research expertise spans a wide range of areas including the effect of sport, exercise and nutrition at the cellular and molecular level, and their contribution to health and well being, biomechanical, nutritional, physiological, pharmacological and psychological factors that affect human performance, and the influence of public health initiatives on human behaviour and vice versa.
We work with sport professionals, clinicians, regulatory bodies, patients and fellow researchers, both national and international, from the worlds of academia and industry to advance knowledge and understanding of factors that are major contributors to human performance and the health and well being of individuals and populations.
Our research support includes a range of bodies and organisations including: the MRC/National Prevention Research Initiative Phase 4; the World Anti-Doping Agency; the Food Standards Agency; The British Academy; the Department for Business Innovation & Skills; the Laboratory of the Government Chemist; the National Measurement Office; the London Development Agency; Neal's Yard Remedies; GlaxoSmithKline; South West London Academic Network; The Organix Foundation; Kingston University Enterprise Investment Fund; EU FP6; ESRC.
Our research is focused into three main themes, namely:
The Safe You research project was conducted by a consortium of global experts across five countries. It investigated the use of performance and appearance enhancing substances (PAES) in 16–25 year-olds, showing a variety of use patterns, motives and attitudes towards these substances.
A second phase, Safe You+ will run until 2018.